- Home
- KODK vs LAB Comparison
KODK vs LAB Comparison
Compare KODK & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KODK
- LAB
- Stock Information
- Founded
- KODK 1880
- LAB 1999
- Country
- KODK United States
- LAB United States
- Employees
- KODK N/A
- LAB N/A
- Industry
- KODK Business Services
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- KODK Consumer Discretionary
- LAB Industrials
- Exchange
- KODK Nasdaq
- LAB Nasdaq
- Market Cap
- KODK 559.0M
- LAB 505.7M
- IPO Year
- KODK N/A
- LAB 2011
- Fundamental
- Price
- KODK $6.46
- LAB $1.30
- Analyst Decision
- KODK
- LAB Buy
- Analyst Count
- KODK 0
- LAB 2
- Target Price
- KODK N/A
- LAB $2.50
- AVG Volume (30 Days)
- KODK 1.6M
- LAB 1.6M
- Earning Date
- KODK 08-15-2025
- LAB 08-11-2025
- Dividend Yield
- KODK N/A
- LAB N/A
- EPS Growth
- KODK N/A
- LAB N/A
- EPS
- KODK 0.52
- LAB N/A
- Revenue
- KODK $1,041,000,000.00
- LAB $169,687,000.00
- Revenue This Year
- KODK N/A
- LAB N/A
- Revenue Next Year
- KODK N/A
- LAB $12.18
- P/E Ratio
- KODK $12.48
- LAB N/A
- Revenue Growth
- KODK N/A
- LAB 33.86
- 52 Week Low
- KODK $4.26
- LAB $0.92
- 52 Week High
- KODK $8.24
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- KODK 47.77
- LAB 49.88
- Support Level
- KODK $6.73
- LAB $1.36
- Resistance Level
- KODK $7.19
- LAB $1.45
- Average True Range (ATR)
- KODK 0.34
- LAB 0.08
- MACD
- KODK -0.05
- LAB -0.01
- Stochastic Oscillator
- KODK 7.14
- LAB 28.57
About KODK Eastman Kodak Company Common New
Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.